Added diagnostic value of routinely measured hematology variables in diagnosing immune checkpoint inhibitor mediated toxicity in the emergency department

BACKGROUND: Immune checkpoint inhibitors (ICI) show remarkable results in cancer treatment, but at the cost of immune‐related adverse events (irAE). irAE can be difficult to differentiate from infections or tumor progression, thereby challenging treatment, especially in the emergency department (ED)...

Descripción completa

Detalles Bibliográficos
Autores principales: Niemantsverdriet, Michael S. A., Vrijsen, Bram E. L., Visser ’t Hooft, Therese, Suijkerbuijk, Karijn P. M., van Solinge, Wouter W., ten Berg, Maarten J., Haitjema, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278460/
https://www.ncbi.nlm.nih.gov/pubmed/37076947
http://dx.doi.org/10.1002/cam4.5956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278460/
https://www.ncbi.nlm.nih.gov/pubmed/37076947
http://dx.doi.org/10.1002/cam4.5956

Ejemplares similares